Shankar Musunuri
Net worth: 4 M $ as of 2026-05-30
Net worth: 4 M $ as of 2026-05-30
Shankar Musunuri founded Nuron Biotech, Inc. in 2009, where he worked as President, Chief Executive Officer & Director in 2013, Ocugen, Inc. in 2013, where he worked as Chairman & Chief Executive Officer, Ocugen, Inc. in 2013, where he is working as Chairman & Chief Executive Officer from 2023, and Ocugen OpCo, Inc. in 2013, where he is working as Executive Chairman & Chief Executive Officer from 2015.
Dr. Musunuri also currently works at OrthoCellix, Inc., as President & Secretary.
Dr. Musunuri also formerly worked at Pfizer Inc., as Senior Director-Global Technology Transfer from 1996 to 2010, Wyeth LLC, as Principal, and Amylin Pharmaceuticals, Inc., as Principal in 1996.
Dr. Musunuri received his doctorate degree from the University of Connecticut and Masters Business Admin degree from The Fuqua School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OCUGEN INC 0.84% | 2026-04-19 | 2,838,374 ( 0.84% ) | 4 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| OCUGEN, INC. | Chief Executive Officer | 2019-09-26 |
Ocugen OpCo, Inc. | Chief Executive Officer | 2015-04-30 |
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 2009-12-31 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Corporate Officer/Principal | 1995-12-31 |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Chief Executive Officer | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Fuqua School of Business
The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical which develops drugs | Health Technology |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Ocugen OpCo, Inc. |
Select your edition
All financial news and data tailored to specific country editions